UAS regulates expression of Hsap\SLC6A3 containing a Cys substitution at R445, identified in a patient with Dopamine transporter deficiency syndrome (DTDS), a distinct type of infantile parkinsonism-dystonia.
Expressing Hsap\SLC6A3R445C.UAS under the control of Scer\GAL4ple.PF in DATfmn homozygotes leads to a decrease in spontaneous walking activity and decreased movement vigor; increased in flight initiation duration; and increase in grooming time. There is a decrease in the number of PPL1 DA neurons.
DATfmn, Hsap\SLC6A3R445C.UAS, Scer\GAL4ple.PF has abnormal locomotor behavior | adult stage phenotype
DATfmn, Hsap\SLC6A3R445C.UAS, Scer\GAL4ple.PF has abnormal flight phenotype
DATfmn, Hsap\SLC6A3R445C.UAS, Scer\GAL4ple.PF has abnormal grooming behavior phenotype
DATfmn, Hsap\SLC6A3R445C.UAS, Scer\GAL4ple.PF has decreased cell number | adult stage phenotype
DATfmn, Hsap\SLC6A3R445C.UAS, Scer\GAL4ple.PF has dopaminergic PPL1 neuron | adult stage phenotype